Trudie Ann Chalder

Prof. Trudie Ann Chalder

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 1993 in Journal of Psychosomatic Research
Verified
Journal Article
Closed access
TCTrudie Ann Chalder
Trudie Ann Chalder
GBG. Berelowitz
G. Berelowitz
TPTeresa Pawlikowska
Teresa Pawlikowska
LWLouise Watts
Louise Watts
SWS. Wessely
S. Wessely
EWE.P. Wallace
E.P. Wallace

1 March 2011 in The Lancet
Verified
Journal Article
Open access
PWPd White
Pd White
KGKa Goldsmith
Ka Goldsmith
AJAL Johnson
AL Johnson
LPL Potts
L Potts
RWR Walwyn
R Walwyn
MSM Sharpe
M Sharpe
Trial findings show cognitive behaviour therapy (CBT) and graded exercise therapy (GET) can be effective treatments for chronic fatigue syndrome, but patients' organisations have reported that these treatments can be harmful and favour pacing and specialist health care. We aimed to assess effectiveness and safety of all four treatments. In our parallel-group randomised trial, patients meeting Oxford criteria for chronic fatigue syndrome were recruited from six secondary-care clinics in the UK and randomly allocated by computer-generated sequence to receive specialist medical care (SMC) alone or with adaptive pacing therapy (APT), CBT, or GET. Primary outcomes were fatigue (measured by Chalder fatigue questionnaire score) and physical function (measured by short form-36 subscale score) up to 52 weeks after randomisation, and safety was assessed primarily by recording all serious adverse events, including serious adverse reactions to trial treatments. Primary outcomes were rated by participants, who were necessarily unmasked to treatment assignment; the statistician was masked to treatment assignment for the analysis of primary outcomes. We used longitudinal regression models to compare SMC alone with other treatments, APT with CBT, and APT with GET. The final analysis included all participants for whom we had data for primary outcomes. This trial is registered at http://isrctn.org, number ISRCTN54285094. We recruited 641 eligible patients, of whom 160 were assigned to the APT group, 161 to the CBT group, 160 to the GET group, and 160 to the SMC-alone group. Compared with SMC alone, mean fatigue scores at 52 weeks were 3·4 (95% CI 1·8 to 5·0) points lower for CBT (p = 0·0001) and 3·2 (1·7 to 4·8) points lower for GET (p = 0·0003), but did not differ for APT (0·7 [-0·9 to 2·3] points lower; p = 0·38). Compared with SMC alone, mean physical function scores were 7·1 (2·0 to 12·1) points higher for CBT (p = 0·0068) and 9·4 (4·4 to 14·4) points higher for GET (p = 0·0005), but did not differ for APT (3·4 [-1·6 to 8·4] points lower; p=0·18). Compared with APT, CBT and GET were associated with less fatigue (CBT p = 0·0027; GET p = 0·0059) and better physical function (CBT p=0·0002; GET p<0·0001). Subgroup analysis of 427 participants meeting international criteria for chronic fatigue syndrome and 329 participants meeting London criteria for myalgic encephalomyelitis yielded equivalent results. Serious adverse reactions were recorded in two (1%) of 159 participants in the APT group, three (2%) of 161 in the CBT group, two (1%) of 160 in the GET group, and two (1%) of 160 in the SMC-alone group. CBT and GET can safely be added to SMC to moderately improve outcomes for chronic fatigue syndrome, but APT is not an effective addition. UK Medical Research Council, Department of Health for England, Scottish Chief Scientist Office, Department for Work and Pensions.

19 March 1994 in BMJ
Verified
Journal Article
Closed access
TPT Pawlikowska
T Pawlikowska
TCTrudie Ann Chalder
Trudie Ann Chalder
SHS R Hirsch
S R Hirsch
PWP Wallace
P Wallace
DWD J M Wright
D J M Wright
SWS C Wessely
S C Wessely
Abstract Objectives : To determine the prevalence of fatigue in the general population and the factors associated with fatigue. Design : Postal survey. Setting : Six general practices in southern England. Subjects : 31 651 men and women aged 18-45 years registered with the practices. Main outcome measures : Responses to the 12 item general health questionnaire and a fatigue questionnaire which included self reported measures of duration, severity, and causes of fatigue. Results - 15 283 valid questionnaires were returned, giving a response rate of 48.3%, (64% after adjustment for inaccuracies in the practice registers). 2798 (18.3%) of respondents reported substantial fatigue lasting six months or longer. Fatigue and psychological morbidity were moderately correlated (r=0.62). Women were more likely to complain of fatigue than men, even after adjustment for psychological distress. The commonest cited reasons for fatigue were psychosocial (40% of patients). Of 2798 patients with excessive tiredness, only 38 (1.4%) attributed this to the chronic fatigue syndrome. Conclusion : Fatigue is distributed as a continuous variable in the community and is closely associated with psychological morbidity.

15 June 2010 in Neurology
Verified
Journal Article
Closed access
LGL.H. Goldstein
L.H. Goldstein
TCTrudie Ann Chalder
Trudie Ann Chalder
CCC. Chigwedere
C. Chigwedere
MKM.R. Khondoker
M.R. Khondoker
JMJ. Moriarty
J. Moriarty
JMJ.D.C. Mellers
J.D.C. Mellers
To compare cognitive-behavioral therapy (CBT) and standard medical care (SMC) as treatments for psychogenic nonepileptic seizures (PNES). Our randomized controlled trial (RCT) compared CBT with SMC in an outpatient neuropsychiatric setting. Sixty-six PNES patients were randomized to either CBT (plus SMC) or SMC alone, scheduled to occur over 4 months. PNES diagnosis was established by video-EEG telemetry for most patients. Exclusion criteria included comorbid history of epilepsy, <2 PNES/month, and IQ <70. The primary outcome was seizure frequency at end of treatment and at 6-month follow-up. Secondary outcomes included 3 months of seizure freedom at 6-month follow-up, measures of psychosocial functioning, health service use, and employment. In an intention-to-treat analysis, seizure reduction following CBT was superior at treatment end (group x time interaction p < 0.0001; large to medium effect sizes). At follow-up, the CBT group tended to be more likely to have experienced 3 months of seizure freedom (odds ratio 3.125, p = 0.086). Both groups improved in some health service use measures and on the Work and Social Adjustment Scale. Mood and employment status showed no change. Our findings suggest that cognitive-behavioral therapy is more effective than standard medical care alone in reducing seizure frequency in PNES patients. This study provides Class III evidence that CBT in addition to SMC, as compared to SMC alone, significantly reduces seizure frequency in patients with PNES (change in median monthly seizure frequency: baseline to 6 months follow-up, CBT group, 12 to 1.5; SMC alone group, 8 to 5).

1 October 2007 in Clinical Psychology Review
Verified
Journal Article
Closed access
VDV. Deary
V. Deary
TCTrudie Ann Chalder
Trudie Ann Chalder
MSM. Sharpe
M. Sharpe

1 March 1997 in American Journal of Psychiatry
Verified
Journal Article
Closed access
ADA Deale
A Deale
TCTrudie Ann Chalder
Trudie Ann Chalder
IMI Marks
I Marks
SWS Wessely
S Wessely